October is Depression and Mental Health Awareness Month — a timely moment to look at how the microscopic world inside us shapes how we feel, think, and behave. Mental health conditions remain stigmatized and under-diagnosed, even as the COVID-19 pandemic has put unprecedented pressure on emotional well-being across every age group.
The gut–brain axis
There is now strong evidence that the microbiome influences brain development, function, and behavior. Microbes and their metabolites are integral components of the bidirectional communication between the gut and brain — what researchers call the gut–brain axis.
Recent reviews have catalogued microbes implicated in human brain health and disease. People with depression show altered gut microbiomes, including depletion of Dialister and reduction in Faecalibacterium. Short-chain fatty acid (SCFA) producers — Collinsella, Blautia, Coprococcus — and bacteria involved in tryptophan metabolism appear especially important. Serotonin, a tryptophan metabolite, is largely produced in the gut and influences sleep, mood, and gut function.
Why sequencing matters
Most microbes that live in and on us cannot be grown in a standard laboratory. Next-generation sequencing sidesteps culture entirely by reading the DNA of every organism in a sample. That gives researchers a complete inventory — not just the species, but the genes those species are carrying. For the gut–brain axis, this lets us connect specific microbial functions to specific behavioral or clinical outcomes — the same approach that's reshaping microbiome-restoring therapies for C. difficile and our understanding of how exercise reshapes the gut.
What this means for diagnostics and therapy
As metagenomic data accumulates, it's beginning to inform a new generation of diagnostics and microbiome-based therapeutics. The same sequencing tools used in clinical infectious disease can map the microbial signatures of mood disorders, neurodevelopmental conditions, and stress responses — pointing toward more precise interventions and away from one-size-fits-all care.
Biotia's role
Biotia is a high-complexity molecular diagnostic lab with NYS CLIA accreditation. Our sequencing services and software platforms translate metagenomic data into actionable microbial and antimicrobial-resistance information — for clinical teams, biopharma partners, and researchers exploring the next frontier of microbiome science.
Frequently asked questions
What is the gut–brain axis?
It's the bidirectional communication network between the gastrointestinal tract and the central nervous system. Microbes and the metabolites they produce — including short-chain fatty acids and tryptophan derivatives like serotonin — are key messengers in this conversation.
Which microbes have been linked to depression?
Studies have observed depletion of Dialister and Faecalibacterium in people with depression, and have associated short-chain fatty acid producers like Collinsella, Blautia, and Coprococcus with mood-modulating metabolic activity.
How does next-generation sequencing help?
NGS catalogs the entire microbial community in a sample without needing to grow each organism. That makes it possible to map subtle shifts in community composition that correlate with brain health and disease.